Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve ...

Early management of obstructive sleep apnea in patients with IPF could slow disease progression and improve outcomes.

KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to ...

The global sleep apnea implants market is projected to expand at a compound annual growth rate (CAGR) of approximately 10% ...

Biotech firm Apnimed plans to seek FDA approval for its sleep apnea drug, with market availability expected by 2027 ...

Medically reviewed by Sanja Jelic, MD Obstructive sleep apnea (OSA) is the most common form of sleep apnea.Central sleep apnea (CSA) is a less common but serious condition.Both OSA and CSA are ...

Many people think that snoring is just a normal part of sleep. But for some, it can be a sign of a serious and often ignored ...

The sleep apnea devices market is primarily driven by the rising prevalence of obstructive sleep apnea (OSA) and related risk factors, as well as by growing public health initiatives, awareness ...